Jeremy Grantham Jazz Pharmaceuticals PLC Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.8 Billion
Q2 2025

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 2,267 shares of JAZZ stock, worth $311,712. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,267

Previous 8,121 72.08%

Holding current value

$311,712

Previous $1.01 Million 76.19%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$97.78 - $126.44 $572,404 - $740,179	-5,854 Reduced 72.08%	2,267 $240,000
Q1 2025 May 14, 2025	SELL	$120.07 - $144.17 $2.04 Million - $2.45 Million	-16,994 Reduced 67.66%	8,121 $1.01 Million
Q4 2024 Feb 13, 2025	BUY	$107.32 - $127.74 $2.37 Million - $2.82 Million	22,108 Added 735.22%	25,115 $3.09 Million
Q3 2024 Nov 13, 2024	SELL	$100.57 - $116.37 $535,434 - $619,553	-5,324 Reduced 63.91%	3,007 $335,000
Q2 2024 Aug 13, 2024	SELL	$103.94 - $118.98 $19.3 Million - $22.1 Million	-185,869 Reduced 95.71%	8,331 $889,000
Q1 2024 May 14, 2024	SELL	$115.19 - $132.77 $1.56 Million - $1.8 Million	-13,558 Reduced 6.53%	194,200 $23.4 Million
Q4 2023 Feb 13, 2024	BUY	$114.26 - $136.0 $2.87 Million - $3.41 Million	25,076 Added 13.73%	207,758 $25.6 Million
Q3 2023 Nov 13, 2023	SELL	$122.0 - $145.31 $157,990 - $188,176	-1,295 Reduced 0.7%	182,682 $23.6 Million
Q2 2023 Aug 14, 2023	SELL	$122.5 - $147.16 $5.48 Million - $6.58 Million	-44,723 Reduced 19.56%	183,977 $22.8 Million
Q1 2023 May 12, 2023	SELL	$133.98 - $160.47 $388,541 - $465,363	-2,900 Reduced 1.25%	228,700 $33.5 Million
Q4 2022 Feb 13, 2023	BUY	$129.72 - $159.85 $3.84 Million - $4.73 Million	29,600 Added 14.65%	231,600 $36.9 Million
Q3 2022 Nov 10, 2022	BUY	$126.59 - $161.18 $645,609 - $822,018	5,100 Added 2.59%	202,000 $26.9 Million
Q2 2022 Aug 12, 2022	SELL	$141.59 - $168.66 $679,632 - $809,568	-4,800 Reduced 2.38%	196,900 $30.7 Million
Q1 2022 May 13, 2022	BUY	$129.64 - $160.7 $2.87 Million - $3.55 Million	22,100 Added 12.31%	201,700 $31.4 Million
Q4 2021 Feb 11, 2022	BUY	$119.87 - $145.67 $371,597 - $451,576	3,100 Added 1.76%	179,600 $22.9 Million
Q3 2021 Nov 12, 2021	BUY	$128.64 - $184.79 $3.68 Million - $5.28 Million	28,600 Added 19.34%	176,500 $23 Million
Q2 2021 Aug 12, 2021	BUY	$160.2 - $186.42 $4.82 Million - $5.61 Million	30,100 Added 25.55%	147,900 $26.3 Million
Q1 2021 May 13, 2021	BUY	$150.19 - $173.5 $4.15 Million - $4.79 Million	27,600 Added 30.6%	117,800 $19.4 Million
Q4 2020 Feb 12, 2021	BUY	$140.71 - $165.05 $12.7 Million - $14.9 Million	90,200 New	90,200 $14.9 Million

Others Institutions Holding JAZZ

# of Institutions

566

Shares Held

62.5M

Call Options Held

563K

Put Options Held

77.8K

View Full List

About Jazz Pharmaceuticals plc

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $8.62B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

More about JAZZ

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account